id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-306798-f28264k3	Walsh, Geraldine M.	Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium	2016-02-23		.txt	text/plain	15308	723	45	Transfusion services can employ indirect measures such as surveillance, hemovigilance, and donor questioning (defense), protein-, or nucleic acid based direct testing (detection), or pathogen inactivation of blood products (destruction) as strategies to mitigate the risk of transmission-transmitted infection. Cost concerns make it likely that pathogen inactivation will be contemplated by blood operators through the lens of health economics and risk-based decision making, rather than in zero-risk paradigms previously embraced for transfusable products. Dr Margaret Fearon, CBS Medical Director, Medical Microbiology, and Assistant Professor, University of Toronto, discussed the current prevalence of classical transfusion-transmissible infections (TTIs) in CBS blood donors, new and emerging infectious diseases, how CBS prepares for and manages new risks, and also addressed new paradigms for risk management. Other transfusion-transmissible diseases are currently being monitored as potential emerging threats to the safety of the blood supply, including babesiosis, hepatitis E, CHIKV, and dengue virus.	./cache/cord-306798-f28264k3.txt	./txt/cord-306798-f28264k3.txt